Details for New Drug Application (NDA): 076262
✉ Email this page to a colleague
NDA 076262 describes LISINOPRIL AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Aurobindo, Chartwell Rx, Corepharma, Epic Pharma Llc, Hikma Intl Pharms, Invagen Pharms, Lupin, Norvium Bioscience, Prinston Inc, Sandoz, Sun Pharm Inds Ltd, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from thirty-three suppliers. Additional details are available on the LISINOPRIL AND HYDROCHLOROTHIAZIDE profile page.
The generic ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
The generic ingredient in LISINOPRIL AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; lisinopril. There are thirty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; lisinopril profile page.
Summary for 076262
| Tradename: | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Applicant: | Sandoz |
| Ingredient: | hydrochlorothiazide; lisinopril |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;10MG | ||||
| Approval Date: | Jul 1, 2002 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 12.5MG;20MG | ||||
| Approval Date: | Jul 1, 2002 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG;20MG | ||||
| Approval Date: | Jul 1, 2002 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
